01 / Contract Profile
W81XWH17C0004 Federal Contract Award
Agency code 2100
MANUFACTURE OF IVAS & PBS FOR FDA LICENSURE.
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
W81XWH17C0004 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$0
FY 2022Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2016 | $2.63M | 1 | — |
| FY 2017 | $521.5K | 1 | −80.1% |
| FY 2018 | $1.66M | 5 | +217.4% |
| FY 2019 | $1.55M | 3 | −6.2% |
| FY 2020 | -$50.9K | 1 | −103.3% |
| FY 2021 | $0 | 1 | +100.0% |
| FY 2022 | $0 | 1 | — |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| DEPT OF DEFENSE | DEPT OF THE ARMY | W4PZ USA MED RSCH ACQUIS ACT |
05 / Contractor
Who holds this federal contract?
DALTON CHEMICAL LABORATORIES INC
UEI Z16FCALBFS22 · CAGE L8660
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541712 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY) | $6.31M | 13 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN93 | R&D- MEDICAL: OTHER (ADVANCED DEVELOPMENT) | $6.31M | 13 | 100.0% |
08 / Place of Performance
Where is the work recorded?
CANADA
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Aug 2, 2022 | P00012 | $0 | W4PZ USA MED RSCH ACQUIS ACTOffice code W81XWH | 541712 | AN93 |
| May 19, 2021 | P00011 | $0 | W4PZ USA MED RSCH ACQUIS ACTOffice code W81XWH | 541712 | AN93 |
| Dec 2, 2020 | P00010 | -$50.9K | W4PZ USA MED RSCH ACQUIS ACTOffice code W81XWH | 541712 | AN93 |
| Nov 7, 2019 | P00009 | $137.3K | W4PZ USA MED RSCH ACQUIS ACTOffice code W81XWH | 541712 | AN93 |
| May 3, 2019 | P00008 | $901.8K | W4PZ USA MED RSCH ACQUIS ACTOffice code W81XWH | 541712 | AN93 |
| Mar 4, 2019 | P00007 | $513.4K | W4PZ USA MED RSCH ACQUIS ACTOffice code W81XWH | 541712 | AN93 |
| Oct 24, 2018 | P00006 | $311.2K | W4PZ USA MED RSCH ACQUIS ACTOffice code W81XWH | 541712 | AN93 |
| Aug 29, 2018 | P00005 | $137.3K | W4PZ USA MED RSCH ACQUIS ACTOffice code W81XWH | 541712 | AN93 |
| May 14, 2018 | P00004 | $1.06M | W4PZ USA MED RSCH ACQUIS ACTOffice code W81XWH | 541712 | AN93 |
| Mar 19, 2018 | P00003 | $6.3K | W4PZ USA MED RSCH ACQUIS ACTOffice code W81XWH | 541712 | AN93 |
| Feb 27, 2018 | P00002 | $135.6K | W4PZ USA MED RSCH ACQUIS ACTOffice code W81XWH | 541712 | AN93 |
| Nov 21, 2017 | P00001 | $521.5K | W4PZ USA MED RSCH ACQUIS ACTOffice code W81XWH | 541712 | AN93 |
| Nov 3, 2016 | Base action | $2.63M | W4PZ USA MED RSCH ACQUIS ACTOffice code W81XWH | 541712 | AN93 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.